glp 1 etf Number of Patients on GLP-1 Weight-Loss Drugs Seem Like Another

If you look at the data as a whole and especially the six studies we cite in our editorial the findings suggest that the cardiovascular and metabolic benefits of GLP-1 drugs extend beyond weight loss, indicating other mechanisms, such as anti-inflammatory or kidney and liver effects, may play a major role

Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe

One study using the GLP-1 receptor agonist liraglutide found that it reduced alcohol consumption in rats that had developed a preference for alcohol

Excessive carnitine/acylcarnitine levels have been associated with the pathogenesis of various cardiomyopathies

Oral vitamin D supplementation for adults with obesity undergoing bariatric surgery